- Raised $40M funding round, Jun 2023
- Raised $11M funding round, Nov 2018
About
ConTIPI Medical develops noninvasive and disposable vaginal devices for women with pelvic floor disorders such as stress urinary incontinence and pelvic organ prolapse. The company's devices are inserted vaginally using a disposable applicator, then open to provide support to predefined vaginal walls. For removal and disposal, a pull of the attached string collapses the device into its original size. One of the company's first devices, for the management of stress urinary incontinence in women, was sold to Kimberly Clark Worldwide Inc. and is now marketed in North America under the name Poise Impressa. ConTIPI Medical also offers ProVate, a ring pessary solution designed for pelvic organ prolapse. The device is inserted by the user in its small form, then enlarges into a ring of up to 91 millimeters. After up to seven days of use, a pull of the string collapses the ring back into its tiny dimensions for removal and disposal. ProVate has a 510(k) clearance from FDA for marketing in the United States, and a CE Mark for marketing in the EU. The ProVate Device is ready for the market, and ConTIPI Medical hired Bourne Partners (Charlotte, NC, United States) as its mergers and acquisitions advisor.
Funding history · 2 rounds · $11.0M total
Q&A
- What is ConTiPi Medical's primary focus?
- ConTiPi Medical develops noninvasive and disposable vaginal devices for women with pelvic floor disorders, such as stress urinary incontinence and pelvic organ prolapse.
- What is the current employee count for ConTiPi Medical?
- ConTiPi Medical has 1-10 employees.
- What is the total amount of funding ConTiPi Medical has raised to date?
- ConTiPi Medical has raised a total of $51,000,000 USD.
- When was ConTiPi Medical's most recent funding round, and who were the investors?
- ConTiPi Medical's most recent funding round occurred in June 2023, with Capital Point as an investor, raising $40,000,000 USD.
- What is the status of ConTiPi Medical's ProVate device?
- The ProVate device has received 510(k) clearance from the FDA for marketing in the United States and a CE Mark for marketing in the EU, and is ready for the market.
- Which company acquired one of ConTiPi Medical's initial devices for stress urinary incontinence?
- Kimberly Clark Worldwide Inc. acquired one of ConTiPi Medical's first devices, which is now marketed in North America under the name Poise Impressa.
- What is ConTiPi Medical's current product stage?
- ConTiPi Medical's product stage is 'released'.
- Which firm is advising ConTiPi Medical on mergers and acquisitions for its ProVate device?
- ConTiPi Medical has hired Bourne Partners as its mergers and acquisitions advisor for the ProVate device.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | contipi.com |
|---|---|
| linkedin.com/company/9456467 | |
| facebook.com/ConTIPIMedical | |
| YouTube | youtube.com/channel/UC48Zu9O4le1j4G-VV6Y2Uew |
Identifiers & details
| Founded | 2014-1 |
|---|---|
| Employees (exact) | 4 |
Radar intelligence
Patents
| EPO | 9 |
|---|
Web history (Wayback)
| Domain | contipi.com |
|---|
Certificate / subdomain footprint
| Subdomains | 4 |
|---|